Articles related to Behavioral Health

LGBTQ+ physicians may face additional burnout-related stressors associated with workplace discrimination, microaggressions, and exclusion, highlighting the potential role of inclusive organizational cultures and supportive professional resources in physician well-being.

Biobehavioral markers previously linked to antidepressant response identified patients with major depressive disorder who were more likely to respond to sertraline or bupropion, although biomarker-guided treatment assignment did not significantly improve outcomes in a prospective validation trial.

Women with bulimia nervosa demonstrated smaller total cortical surface area and reduced nucleus accumbens volume compared with healthy controls in a large international neuroimaging study, with more frequent binge-eating episodes associated with additional structural differences across brain regions involved in reward, cognitive control, and interoception.

The FDA has approved once-monthly subcutaneous olanzapine for adults with schizophrenia, supported by placebo-controlled trial data showing symptom improvement and sustained efficacy through 48 weeks, while eliminating several logistical requirements associated with treatment initiation.

Cannabis use at psychiatric admission was associated with a higher risk of early rehospitalization among young adults hospitalized for bipolar or psychotic disorders, although the association weakened over time and was no longer statistically significant by six months.

Growing evidence suggests that exposure to natural environments may improve mood, attention, and selected cognitive functions, although the current literature remains insufficient to establish nature-based interventions as validated treatments for psychiatric disorders.